[Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use*; D010919:Placebos; D011341:Probucol / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D008055:Lipids; D010636:Phenols; D010919:Placebos; D002784:Cholesterol; D011341:Probucol
Le probucol : comparaison de son action à celle d'un placebo dans les hyperlipoprotéinémies de type II.